摘要 |
This invention describes novel triazole compounds of formula IX: wherein Z<SUP>1 </SUP>is nitrogen or CR<SUP>9 </SUP>and Z<SUP>2 </SUP>is nitrogen or CH, provided that at least one of Z<SUP>1 </SUP>and Z<SUP>2 </SUP>is nitrogen; G is Ring C or Ring D; Ring C is selected from a phenyl, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, or 1,2,4-triazinyl ring, wherein said Ring C has one or two ortho substituents independently selected from -R<SUP>1</SUP>; Ring D is a 5-7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl; R<SUP>x </SUP>and R<SUP>y </SUP>are independently selected from T-R<SUP>3</SUP>, or R<SUP>x </SUP>and R<SUP>y </SUP>are taken together with their intervening atoms to form a fused ring; R<SUP>1</SUP>, R<SUP>3</SUP>, and T are as described in the specification. The compounds are useful as protein kinase inhibitors, especially as inhibitors of GSK-3 and Aurora, for treating diseases such as diabetes, cancer, and Alzheimer's disease.
|